Its an environment where multiple service providers collaborate seamlessly, enabling us to effectively support children and their families
In the US, GLP-1 spending rose from $13 to $72 billion in just five years, making approval tough for patients without diabeteseven as data for arthritis risk and cardiovascular benefits grow
Physician-supervised weight loss with FDA-approved GLP-1 medications, personalized nutrition, and ongoing clinical support
This chart isnt granular enough, but theres a formula you can use to calculate it
A systematic review of GLP-1 agonist use in kidney transplant recipients found improvements in glycaemic control and body weight without significant adverse effects on graft function or immunosuppressant levels
While brand-name GLP-1s continue to significantly lead the marketplace, the lower cost of compounded or custom-mixed varieties is fueling a shift away from brand-name choices and is likely making GLP-1s available to broader sectors of the population